Management des T1a Stimmlippenkarzinoms

Translated title of the contribution: Management of T1a vocal fold carcinoma

R. Reiter, S. Brosch, E. Smith, A. Pickhard

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Management of T1a Vocal Fold Carcinoma About 2/3 of the larynxcarcinomas affect the vocal chords. The main risk factor is smoking. Carcinomas in this localisation often arise from leukoplakias with dysplasia. A typical symptom is dysphonia. Arrest of vibration in microlaryngostroboscopy is a hint that a carcinoma could be present. Transoral lasercordectomy or radiotherapy show equivalent oncological results and results in quality of voice in the treatment of vocal fold carcinoma (T1a). As lymph node and distant metastasis are very rare, follow-up can concentrate on microlaryngoscopy. In case of a suspicious area on the vocal fold, biopsy of the affected tissue is needed to plan correct treatment. The prognosis of the T1 vocal chord carcinoma is quite good with a 5-year survival rate of almost 100%.

Translated title of the contributionManagement of T1a vocal fold carcinoma
Original languageGerman
Pages (from-to)797-807
Number of pages11
JournalLaryngo- Rhino- Otologie
Issue number12
StatePublished - 8 Aug 2013


Dive into the research topics of 'Management of T1a vocal fold carcinoma'. Together they form a unique fingerprint.

Cite this